Eisai signs tropical disease deal
November 12, 2013Research and Development, Sales and Marketing Disease, Eisai, Japan, broad, ntd, tropical
Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …
Novartis takes top honours in ISPE facility competition
November 12, 2013Manufacturing and Production Novartis, WHO, foya, holly springs
Novartis’ cell culture facility in the US for the production of influenza vaccines has claimed the top prize in the …
NICE needs more Velcade data
November 12, 2013Sales and Marketing NHS, NICE, Velcade, eric low
NICE has slowed the progress of Janssen Cilag’s Velcade towards becoming an NHS treatment for multiple myeloma by asking the …
Celgene hires new medical director
November 12, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, kilcoyne
Biopharma firm Celgene has announced the appointment of Dr Adrian Kilcoyne as its new medical director. He will take up …
AstraZeneca ups cancer drug production at Alderley Park
November 11, 2013Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Zoladex, alderley park
AstraZeneca says it plans to invest around £120 million in a new cancer drug manufacturing facility at its plant in …
Sanofi to produce weight-loss drug for Orexigen
November 11, 2013Manufacturing and Production, Sales and Marketing Contrave, FDA, Sanofi, orexigen
Sanofi has agreed a deal to manufacture Orexigen Therapeutics’ weight-loss candidate Contrave outside North America. Under the commercial supply agreement, …
Shire spends $4.2 billion on ViroPharma purchase
November 11, 2013Sales and Marketing Cinryze, Firazyr, Shire, Viropharma
Shire has announced a $4.2 billion deal to buy US-based ViroPharma in a pact that is designed to bolster the …
Cancer Research backs ‘unique’ database
November 11, 2013Research and Development, Sales and Marketing Cancer, Database, ICR, cansar
An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …
Novartis sheds blood diagnostics for $1.7 billion
November 11, 2013Sales and Marketing Genoptix, Novartis, blood, grifols
Novartis has announced the sale of its blood transfusion diagnostics unit to the specialist Spanish firm Grifols for $1.67 billion.Headquartered …
‘Fatal’ safety concerns throw doubt on Lemtrada
November 11, 2013Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi
An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …
The CDF: friend and foe?
November 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, Cancer, NICE, eric low
Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …
New chief executive for the International Diabetes Federation
November 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing diabetes, petra wilson
The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its chief executive. Wilson joins IDF from Cisco, where …
BMS abandons hep C, diabetes and neuroscience
November 11, 2013Sales and Marketing BMS, HIV, diabetes, hep C
Bristol-Myers Squibb is admitting defeat in hepatitis C, diabetes and neuroscience and will abandon research in these areas in a …
Bayer submits Eylea in EU for DME
November 8, 2013Sales and Marketing Bayer, DME, EMA, Eylea, FDA
Bayer HealthCare is seeking to extend the licence of its VEGF Trap-Eye, which is already marketed as Eylea in various …
EMA questions Brilinta data
November 8, 2013Sales and Marketing Brilinta, EMA, astrazenca, heart, ticagrelor
The European Medicines Agency is demanding more information from AstraZeneca on its troubled heart pill Brilinta. This rounds off a …
Genticel appoints vice president


November 8, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genticel, moeller
Biopharma firm Genticel has appointed Dr Gerald Moeller to sit on its supervisory Board as a vice president. Moeller has …
UK to launch DNA database
November 8, 2013Sales and Marketing DNA, UK, crispr, genome
Volunteers prepared to share their DNA with the rest of the world are being sought by scientists in the UK, …
Alzheimer’s drug development ‘must speed up’
November 7, 2013Research and Development, Sales and Marketing Alzheimer's, CEO, drug development
Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …
Shire to cut UK research jobs says source
November 7, 2013Research and Development, Sales and Marketing England, Shire, UK, cuts
Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …
PPRS: thumbs-down from pharma
November 7, 2013Sales and Marketing ABPI, NHS, PPRS, Pfizer, VBP
A missed opportunity for patients, which creates financial problems for smaller companies while stifling life science investment – these are …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
